AOD-9604 Import Supplier — Poland
Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.
Aarise Healthcare exports AOD-9604 (CAS: 221231-10-3) to research institutions in Poland. Our WHO-GMP certified facility in India supplies 98%+ purity AOD-9604 for lipolytic peptide and fat metabolism research.
AOD-9604 Export Specifications for Poland
| Compound | AOD-9604 |
| CAS Number | 221231-10-3 |
| Purity | 98%+ (HPLC verified) |
| Form | Lyophilised powder |
| Regulatory Reference | URPL |
| Shipping | DHL/FedEx temperature-controlled |
| Transit to Poland | 5-10 business days |
| Documentation | CoA, HPLC, MS, export docs |
Research Applications of AOD-9604
AOD-9604 is used in lipolytic peptide and fat metabolism research. Research institutions in Poland source this compound for preclinical studies under applicable URPL research regulations.
Why Poland Researchers Source AOD-9604 from India
- WHO-GMP certified Indian manufacturer — internationally recognised compliance
- Competitive pricing for bulk research quantities
- Full export documentation package for URPL compliance
- Temperature-controlled DHL/FedEx shipping to Poland
- Dedicated international research supply team
- 98%+ purity guaranteed with independent third-party CoA
Related Peptides in Poland
Semaglutide in Poland | Tirzepatide in Poland | Retatrutide in Poland | Liraglutide in Poland
AOD-9604 — Other Countries
AOD-9604 in USA | AOD-9604 in UK | AOD-9604 in Germany | AOD-9604 in Australia
Source from India — Key Manufacturing Cities
AOD-9604 in Mumbai, India | AOD-9604 in Delhi, India | AOD-9604 in Hyderabad, India | AOD-9604 in Bangalore, India
Request AOD-9604 for your Poland research facility: Send your institution details and quantity requirements. We respond within 24 hours with FOB pricing and export documentation.
